New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 20, 2012
07:15 EDTRADRite Aid reports Q3 SSS down 1.5%
Same store sales for the quarter decreased 1.5% over the prior year 13-week period, consisting of a 1.1% increase in front end sales offset by a 2.7% decrease in pharmacy sales. Pharmacy sales included an approximate 924 basis point negative impact from new generic introductions. The number of prescriptions filled in same stores increased 3.6% over the prior year period, which includes the benefit of additional prescriptions resulting from the Walgreens (WAG)-Express Scripts (ESRX) dispute. Prescription sales accounted for 67.8% of total drugstore sales, and third party prescription revenue was 96.5% of pharmacy sales.
News For RAD From The Last 14 Days
Check below for free stories on RAD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 25, 2014
13:13 EDTRADEinhorn bought Lam Research shares, sold Rite Aid last quarter
Subscribe for More Information
July 24, 2014
16:09 EDTRADRite Aid names Darren Karst as executive VP, CFO
Subscribe for More Information
16:05 EDTRADRoundy's CFO Karst leaves for Rite-Aid, names Michael Turzenski as CFO
Roundy’s (RNDY) announced that Darren Karst, Roundy’s executive VP and CFO will be leaving the company to join Rite Aid (RAD) as its executive VP and CFO. Karst will remain with Roundy’s through August 9. Michael Turzenski, currently Roundy’s group VP and Chief Accounting Officer, has been appointed group VP, CFO by Roundy’s board. Turzenski has served as group VP, Chief Accounting Officer since February 2012. Turzenski joined Roundy’s in 2007 as VP, controller.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use